1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. Executive Summary
3.1. Outlook in the In Vitro Diagnostics Market
3.2. Opportunities in the In Vitro Diagnostics Market
4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Geriatric population and prevalence of chronic and infectious diseases in Americas
4.2.1.2. Growing awareness on self-testing and personalized medicine
4.2.1.3. Increasing adoption automated instruments and equipment in laboratories
4.2.1.4. Increasing deployment of Point-of-Care testing facilities
4.2.2. Restraints
4.2.2.1. Unfavorable reimbursement
4.2.3. Opportunities
4.2.3.1. Development of condition-specific markers and tests
4.2.3.2. Attractive companion diagnostics
4.2.3.3. Growth opportunities in emerging countries
4.2.4. Challenges
4.2.4.1. Changing the regulatory landscape
4.2.4.2. Operational limitations faced in conducting diagnostic tests
4.3. Porter's Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. Global In Vitro Diagnostics Market, by Component
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Data Management Software
5.4. Instruments
5.5. Reagents & Kits
5.6. Services
6. Global In Vitro Diagnostics Market, by Technology
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Clinical Chemistry
6.3.1. Basic Metabolic Panel
6.3.2. Electrolyte Panel
6.3.3. Lipid Profile
6.3.4. Liver Panel
6.3.5. Renal Profile
6.3.6. Specialty Chemical Tests
6.3.7. Thyroid Function Panel
6.4. Coagulation & Hemostasis
6.5. Hematology
6.6. Immunochemistry
6.6.1. Enzyme-Linked Immunosorbent Assay
6.6.1.1. Chemiluminescence Immunoassays
6.6.1.2. Colorimetric Immunoassays
6.6.1.3. Fluorescence Immunoassays
6.6.2. Enzyme-Linked Immunospot Assays
6.6.3. Radioimmunoassay
6.6.4. Rapid Test
6.6.5. Western Blotting
6.7. Microbiology
6.8. Molecular Diagnostics
6.8.1. DNA Sequencing & Next-Generation Sequencing
6.8.2. Hybridization
6.8.3. Isothermal Nucleic Acid Amplification Technology
6.8.4. Microarray
6.8.5. Polymerase Chain Reaction
6.9. Urinalysis
7. Global In Vitro Diagnostics Market, by End User
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Hospitals & Care Providers
7.4. Laboratories
7.5. Patient Self-Testing
8. Global In Vitro Diagnostics Market, by Application
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Autoimmune Diseases
8.4. Cardiology
8.5. Diabetes
8.6. Drug Testing
8.7. HIV/Aids
8.8. Infectious Diseases
8.9. Nephrology
8.10. Oncology
9. Global In Vitro Diagnostics Market, by Geography
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. Americas
9.3.1. Overview
9.3.2. Market Sizing & Forecasting
9.3.3. Argentina
9.3.4. Brazil
9.3.5. Canada
9.3.6. Mexico
9.3.7. United States
9.4. Asia-Pacific
9.4.1. Overview
9.4.2. Market Sizing & Forecasting
9.4.3. Australia
9.4.4. China
9.4.5. India
9.4.6. Japan
9.5. Europe, Middle East & Africa
9.5.1. Overview
9.5.2. Market Sizing & Forecasting
9.5.3. France
9.5.4. Germany
9.5.5. Italy
9.5.6. Spain
9.5.7. United Kingdom
10. Competitive Landscape
10.1. 360iResearch FPNV Positioning Matrix for Global In Vitro Diagnostics Market
10.2. Market Vendor Ranking Analysis for Global In Vitro Diagnostics Market
10.3. Competitive News Feed Analysis for Global In Vitro Diagnostics Market
11. Company Usability Profiles
11.1. Abbott Laboratories, Inc.
11.1.1. Overview
11.1.2. Strategy
11.1.3. SWOT
11.2. Agilent Technologies
11.2.1. Overview
11.2.2. Strategy
11.2.3. SWOT
11.3. Arkray, Inc.
11.3.1. Overview
11.3.2. Strategy
11.3.3. SWOT
11.4. Becton, Dickinson and Company
11.4.1. Overview
11.4.2. Strategy
11.4.3. SWOT
11.5. Bio-Rad Laboratories, Inc.
11.5.1. Overview
11.5.2. Strategy
11.5.3. SWOT
11.6. Biomerieux Sa
11.7. Danaher Corporation
11.8. Diasorin
11.9. Johnson & Johnson
11.10. Ortho Clinical Diagnostics
11.11. Qiagen
11.12. Roche Diagnostics
11.13. Siemens AG
11.14. Sysmex Corporation
11.15. Thermo Fisher Scientific
12. Appendix
12.1. Discussion Guide
12.2. Top Reports
12.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.3. Author Details